参考文献/References:
[1] 于 洁,张 青,杨为伟,等.辨证治疗晚期结直肠癌疗效观察[J].陕西中医,2015,36(5):522-524.
[2] 曹巍巍,郭修田.结直肠癌原位移植造模技术研究进展[J].陕西医学杂志,2022,51(6):764-766.
[3] 王敬东,张庆尧.Mfolfox6方案联合西妥昔单抗和辛伐他汀治疗K-Ras突变结直肠癌疗效及对预后的影响[J].陕西医学杂志,2022,51(10):1290-1293.
[4] 闫平钊,杨小花,王建华.中性粒细胞/淋巴细胞比值对Ⅱ期结直肠癌手术预后意义研究[J].陕西医学杂志,2018,47(6):751-754.
[5] 罗 星,陈 琪.健脾消癌方联合化疗对大肠癌患者肿瘤标志物及预后的影响[J].陕西中医,2022,43(9):1249-1251.
[6] Amin MB,Greene FL,Edge SB,et al.The eighth edition ajcc cancer staging manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging[J].CA Cancer J Clin,2017,67(2):93-99.
[7] 应乐倩,王德强,余 晖,等.基于细胞焦亡与炎症反应相关基因构建肝细胞癌预后风险评估模型及验证[J].浙江医学,2022,44(3):250-257.
[8] 牛志强,莱智勇,高 明,等.全身炎症反应指数评估消化系统恶性肿瘤患者预后的研究进展[J].国际外科学杂志,2021,48(2):132-136.
[9] Feng LW,Li J,Liang LF,et al.A predictive scoring system based on inflammatory and tumor markers for gastric cancer patients undergoing curative resection[J].Cancer Manag Res,2020,12:3937-3948.
[10] 毛富巍,曹英豪,邓胜和,等.基于NLR、PLR、WLR、MLR的系统炎症标志物评分与结直肠癌患者术后生存时间的相关性[J].华中科技大学学报:医学版,2022,51(2):229-234.
[11] Jakubowska K,Koda M,Grudzińska M,et al.Monocyte-to-lymphocyte ratio as a prognostic factor in peripheral whole blood samples of colorectal cancer patients[J].World J Gastroenterol,2020,26(31):4639-4655.
[12] Carruthers R,Tho LM,Brown J,et al.Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer[J].Colorectal Dis,2012,14(10):e701-e707.
[13] 朱飞宇,徐庆梅,朱 建,等.NLRP3-ASC-Caspase-1信号通路在慢性心力衰竭患者外周血单核细胞中的表达[J].海南医学院学报,2021,27(14):1052-1058.
[14] 黎晨辉,杨少芬,卢庆莉,等.系统免疫炎症指数与慢性心力衰竭急性发作患者院内死亡的相关性研究[J].心肺血管病杂志,2021,40(7):658-662.
[15] 侯文运,吴 斌,林国乐,等.术前外周血白细胞相关炎性指标预测结肠癌预后价值分析[J].中国实用外科杂志,2021,41(4):433-437,442.
[16] 吴文龙,贾玉松,张文杰,等.新型炎性指标AAR-GPR对肝细胞癌患者术后预后的预测价值[J].中国普通外科杂志,2022,31(1):31-41.
[17] Misiewicz A,Dymicka-Piekarska V.Fashionable,but what is their real clinical usefulness? NLR,LMR,and PLR as a promising indicator in colorectal cancer prognosis: A systematic review[J].J Inflamm Res,2023(1):69-81.
[18] 贾琳琳,陈进宝,池华博文,等.结肠癌细胞调节M2型巨噬细胞极化促进化疗耐药的研究[J].中国临床药理学杂志,2022,38(21):2564-2567.
[19] 吴海芳,张海波,黄素静,等.Nogo-B促进M2型巨噬细胞极化在卵巢癌细胞增殖、侵袭和血管生成中的作用研究[J].现代肿瘤医学,2023,31(5):828-834.
[20] 吕凤红,郭甲森,黄尤光.结直肠癌肿瘤微环境中M1型巨噬细胞的研究进展[J].现代肿瘤医学,2023,31(2):363-366.
相似文献/References:
[1]柯东平,毛俊倩,刘 琪,等.TRIM21调控人结直肠癌细胞增殖分子机制研究*[J].陕西医学杂志,2019,(6):691.
KE Dongping,MAO Junqian,LIU Qi,et al.Study on molecular mechanisms of TRIM21 in regulating proliferation of colorectal cancer[J].,2019,(6):691.
[2]张 慧,陈景志,陈建立△,等.DCC和MKK4基因在结直肠癌组织中的表达及临床意义*[J].陕西医学杂志,2019,(8):968.
ZHANG Hui,CHEN Jingzhi,CHEN Jianli,et al.Expression and clinical significance of DDC and MKK4 genes in colorectal cancer tissue[J].,2019,(6):968.
[3]高怀军,余 伟.腹腔镜结直肠癌根治术治疗结直肠癌临床疗效及对患者胃肠功能的影响[J].陕西医学杂志,2019,(8):990.
GAO Huaijun,YU Wei..Clinical study of laparoscopic radical resection in the treatment of colorectal cancer in and its influence on gastrointestinal function[J].,2019,(6):990.
[4]赵英旋,白玉勤.结直肠癌患者肿瘤出芽情况与临床病理特征、程序性死亡受体1及程序性死亡配体1表达相关性研究[J].陕西医学杂志,2021,50(6):747.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.027]
ZHAO Yingxuan,BAI Yuqin.Correlation between tumor budding and clinicopathological characteristics,expression of PD-1 and PD-L1 in CRC[J].,2021,50(6):747.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.027]
[5]马 骞,朱 军,蔡梦珊,等.基于exoRBase外泌体数据库结直肠癌竞争性内源RNA网络构建及富集分析[J].陕西医学杂志,2021,50(7):797.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.007]
MA Qian,ZHU Jun,CAI Mengshan,et al.Construction and enrichment analysis of competing endogenous RNA network for colorectal cancer based on the exoRBase database[J].,2021,50(6):797.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.007]
[6]章玉玲,周 岳.结直肠癌患者血清循环肿瘤细胞、糖类抗原24-2、糖类抗原19-9水平及其与临床病理特征关系[J].陕西医学杂志,2022,51(3):322.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.013]
ZHANG Yuling,ZHOU Yue.Serum circulating tumor cells,carbohydrate antigen 24-2 and carbohydrate antigen 19-9 levels in patients with colorectal cancer and their relationship with clinicopathological features[J].,2022,51(6):322.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.013]
[7]张利伟,胡海燕.粪便硫酸类肝素蛋白多糖2与分泌型卷曲相关蛋白2基因甲基化检测在结直肠癌筛查中的应用价值[J].陕西医学杂志,2022,51(3):366.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.024]
ZHANG Liwei,HU Haiyan.Application value of feces detection of syndecan-2 and secreted frizzled related protein 2 gene methylation in colorectal cancer screening[J].,2022,51(6):366.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.024]
[8]曹巍巍,郭修田.结直肠癌原位移植造模技术研究进展[J].陕西医学杂志,2022,51(6):764.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.029]
CAO Weiwei,GUO Xiutian.Research progress of orthotopic transplantation technology for colorectal cancer[J].,2022,51(6):764.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.029]
[9]张言言,韩 刚,曹 羽,等.同源盒基因10调控胰岛素样生长因子结合蛋白3与肠癌细胞5-氟尿嘧啶抵抗的关系研究[J].陕西医学杂志,2022,51(7):771.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.001]
ZHANG Yanyan,HAN Gang,CAO Yu,et al.Relationship between regulation of IGFBP3 by HOXD10 and 5-fluorouracil resistance in colorectal cancer cells[J].,2022,51(6):771.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.001]
[10]张晓峰,冯 景,季飞燕,等.结直肠癌术后辅助化疗患者肠内营养不耐受影响因素及小野寺预后营养指数预测价值分析[J].陕西医学杂志,2022,51(9):1114.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.016]